Denosumab Subcutaneous and Emtricitabine, nelfinavir, and tenofovir
Determining the interaction of Denosumab Subcutaneous and Emtricitabine, nelfinavir, and tenofovir and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: denosumab
Brand name: Prolia, Xgeva
Synonyms: Denosumab
Generic Name: emtricitabine / nelfinavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Viracept
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Denosumab Subcutaneous-Emtricitabine, rilpivirine, and tenofovir
- Denosumab Subcutaneous-Emtricitabine, Rilpivirine, and Tenofovir Alafenamide
- Denosumab Subcutaneous-Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate
- Denosumab Subcutaneous-Emtriva
- Denosumab Subcutaneous-Emtriva (Emtricitabine Capsules)
- Denosumab Subcutaneous-Emtriva (Emtricitabine Solution)
- Emtricitabine, nelfinavir, and tenofovir-Denovo
- Emtricitabine, nelfinavir, and tenofovir-Dent-O-Kain/20
- Emtricitabine, nelfinavir, and tenofovir-Denti-Care Denti-Freeze Topical Anesthetic
- Emtricitabine, nelfinavir, and tenofovir-DentiPatch
- Emtricitabine, nelfinavir, and tenofovir-Deoxycholic acid
- Emtricitabine, nelfinavir, and tenofovir-Deoxycholic acid Subcutaneous